Bhk Investment Advisors, LLC Fibrogen Inc Transaction History

Bhk Investment Advisors, LLC

$268 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.79 - $2.83 $21,286 - $76,254	-26,945 Reduced 31.86%	57,625 $49,000
Q2 2023 Aug 07, 2023	SELL	$2.49 - $20.59 $1,817 - $15,030	-730 Reduced 0.86%	84,570 $228,000
Q1 2023 May 09, 2023	SELL	$15.95 - $25.18 $35,887 - $56,655	-2,250 Reduced 2.57%	85,300 $1.59 Million
Q4 2022 Feb 02, 2023	BUY	$13.27 - $17.73 $1,327 - $1,773	100 Added 0.11%	87,550 $1.4 Million
Q2 2022 Aug 04, 2022	BUY	$7.94 - $12.96 $214,380 - $349,920	27,000 Added 44.67%	87,450 $923,000
Q1 2022 May 05, 2022	BUY	$12.02 - $16.79 $4,808 - $6,716	400 Added 0.67%	60,450 $727,000
Q4 2021 Feb 07, 2022	SELL	$9.93 - $15.39 $101,782 - $157,747	-10,250 Reduced 14.58%	60,050 $847,000
Q3 2021 Nov 01, 2021	BUY	$10.18 - $26.64 $256,536 - $671,328	25,200 Added 55.88%	70,300 $718,000
Q2 2021 Aug 03, 2021	BUY	$18.57 - $35.68 $134,632 - $258,680	7,250 Added 19.15%	45,100 $1.2 Million
Q1 2021 Apr 19, 2021	BUY	$31.0 - $55.72 $4,650 - $8,358	150 Added 0.4%	37,850 $1.4 Million
Q4 2020 Feb 01, 2021	BUY	$37.09 - $48.97 $5,563 - $7,345	150 Added 0.4%	37,700 $1.4 Million
Q3 2020 Oct 22, 2020	SELL	$40.47 - $45.5 $32,376 - $36,400	-800 Reduced 2.09%	37,550 $1.54 Million
Q2 2020 Jul 30, 2020	BUY	$32.57 - $42.83 $35,827 - $47,113	1,100 Added 2.95%	38,350 $1.55 Million
Q1 2020 Apr 30, 2020	BUY	$23.3 - $45.96 $208,535 - $411,342	8,950 Added 31.63%	37,250 $1.29 Million
Q4 2019 Feb 11, 2020	BUY	$34.58 - $48.06 $53,599 - $74,493	1,550 Added 5.79%	28,300 $1.21 Million
Q3 2019 Oct 31, 2019	BUY	$36.98 - $48.45 $122,033 - $159,885	3,300 Added 14.07%	26,750 $989,000
Q2 2019 Aug 02, 2019	BUY	$35.13 - $55.53 $115,929 - $183,249	3,300 Added 16.38%	23,450 $1.06 Million
Q1 2019 May 03, 2019	BUY	$42.83 - $59.91 $87,801 - $122,815	2,050 Added 11.33%	20,150 $1.1 Million
Q4 2018 Feb 04, 2019	BUY	$37.97 - $60.16 $115,808 - $183,488	3,050 Added 20.27%	18,100 $838,000
Q2 2018 Aug 07, 2018	BUY	$44.9 - $64.95 $32,058 - $46,374	714 Added 4.98%	15,050 $942,000
Q1 2018 May 09, 2018	BUY	$45.35 - $61.65 $24,307 - $33,044	536 Added 3.88%	14,336 $662,000
Q4 2017 Feb 08, 2018	BUY	$41.95 - $60.1 $578,910 - $829,380	13,800	13,800 $654,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bhk Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bhk Investment Advisors, LLC with notifications on news.

Account